Updated

Healthcare distributor McKesson announced a $2.25 billion acquisition to expand its presence in precision oncology medicine, extending the company's diversification beyond its core pharmaceutical distribution business. The deal reflects growing industry interest in specialized cancer-treatment infrastructure. The acquisition adds to McKesson's recent string of investments aimed at capturing higher-margin healthcare services, as traditional distribution margins remain under pressure.